1. Home
  2. CORT vs BYD Comparison

CORT vs BYD Comparison

Compare CORT & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • BYD
  • Stock Information
  • Founded
  • CORT 1998
  • BYD 1973
  • Country
  • CORT United States
  • BYD United States
  • Employees
  • CORT N/A
  • BYD N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • BYD Hotels/Resorts
  • Sector
  • CORT Health Care
  • BYD Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • BYD Nasdaq
  • Market Cap
  • CORT 7.5B
  • BYD 6.1B
  • IPO Year
  • CORT N/A
  • BYD 1993
  • Fundamental
  • Price
  • CORT $69.15
  • BYD $86.35
  • Analyst Decision
  • CORT Strong Buy
  • BYD Buy
  • Analyst Count
  • CORT 4
  • BYD 14
  • Target Price
  • CORT $142.00
  • BYD $86.08
  • AVG Volume (30 Days)
  • CORT 856.9K
  • BYD 1.5M
  • Earning Date
  • CORT 08-05-2025
  • BYD 07-24-2025
  • Dividend Yield
  • CORT N/A
  • BYD 0.83%
  • EPS Growth
  • CORT 8.36
  • BYD 26.05
  • EPS
  • CORT 1.14
  • BYD 6.48
  • Revenue
  • CORT $685,446,000.00
  • BYD $4,027,724,000.00
  • Revenue This Year
  • CORT $35.85
  • BYD $1.55
  • Revenue Next Year
  • CORT $35.22
  • BYD $2.15
  • P/E Ratio
  • CORT $60.53
  • BYD $13.31
  • Revenue Growth
  • CORT 30.93
  • BYD 6.40
  • 52 Week Low
  • CORT $32.33
  • BYD $52.76
  • 52 Week High
  • CORT $117.33
  • BYD $87.76
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.05
  • BYD 66.95
  • Support Level
  • CORT $67.44
  • BYD $81.97
  • Resistance Level
  • CORT $73.78
  • BYD $83.35
  • Average True Range (ATR)
  • CORT 2.08
  • BYD 2.23
  • MACD
  • CORT -0.31
  • BYD 0.13
  • Stochastic Oscillator
  • CORT 26.97
  • BYD 83.55

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.

Share on Social Networks: